An <i>in vivo</i> genome‐wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancerMohammad Sultan, Paola Marcato, Brianne M. Cruickshank et al.|Molecular Oncology|2021Cited by 12
Author response for "An in vivo genome‐wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer"Mohammad M. Sultan, Paola Marcato, Jacob T. Nearing et al.|Unknown|2021Cited by 0